At the beginning of May 1981 an unusual outbreak of pulmonary disease was recognized in Spain in Madrid and in the provinces north-west of Madrid. Although the exact date of the first cases has not yet been established, there is some evidence that it may have been 10 days earlier in April, the number of cases rose rapidly and reached a peak in early June (Rigau-Perez et al. , 1984; WHO, 1984) .
Initially, the causal agent was thought to be infective and the disease an atypical pneumonia caused by mycoplasma. However, the prevalence of severe pulmonary oedema and its rapid disappearance after 3-7 days threw some doubt on this diagnosis. Other signs such as exanthema and a considerable eosinophilia underlined the unusual nature of the disease and raised the possibility that it might be a toxic phenomena. A search for environmental factors finally provided a very strong correlation between the disease and the consumption of clandestine olive oil sold by street vendors in 5-litre containers at well below the usual market price for this type of oil (Tabuenca, 1981) . This information was reported to the health authorities in Spain on 9 June and on 10 June 1981 it was announced in the media. When it looked as though the warnings were being ignored, probably due to a plethora of absurd hypotheses which had been discussed by the media, an announcement was made on 26 June by the Minister of Health and Consumer Affairs that the government would replace toxic oil with pure olive oil. The number of cases of the disease dramatically decreased after this announcement; however, there is more recent evidence that the peak of reported cases was a few days earlier.
The total number of recorded cases is in excess of 20 000. Up to June 1984, 351 patients have been diagnosed to have died from toxic oil syndrome, an additional 57 deaths have either not been evaluated or, although suspected, could not be finally confirmed as due to toxic oil syndrome. As will be described later the disease has an acute pneumonic and a chronic neurologic or paralytic phase. As a result of the development of the chronic manifestations many patients are still in hospital or require rehabilitation.
Epidemiological evidence
After the initial investigation (Tabuenca, 1981) where particular emphasis was placed on small children who spend most of their time at home and have a controlled and constant food intake, several case control studies have been carried out (Rigau-Perez et al., 1984) . The only significant factor to emerge from these studies is an association of the disease with the consumption of illegal oil sold in 5-litre containers and purchased from itinerant salesmen. When a particular salesman was identified the correlation became even more striking. However, the difference between case families and control families was not absolute; although all of the case families consumed illegal oil, a small proportion of the control families also stated that they had done so.
Other evidence also supporting the toxic oil hypothesis was found in case or cluster investigations.
From some studies the interval between the first ingestion of the oil and the onset of symptoms was 1-2 weeks, although from one of the cluster investigations a latency period of 1-3 months was seen. An explanation for this discrepancy is not known (WHO, 1984;  Annex 2). Greater rates of hospitalization for women were found in all age groups and in one study a dose-response relation was seen (Rigau-Perez et al. , 1984) .
The only hypothesis that fits the evidence now available is that the agent which caused the toxic oil syndrome was a constituent of cheap oil sold from door to door. Other possibilities such as infective agents, metals, mineral oils, mycotoxins, paraquat and organochlorine or organophosphorus insecticides have not been substantiated.
It cannot be overemphasized that the association between the disease syndrome and the consumption of adulterated cooking oil rests exclusively on epidemiological evidence because of the inability to reproduce the disease in animals and the absence of any viable hypothesis as to what the responsible chemical agent in the oil could be.
Clinical and pathological criteria for the toxic oil syndrome
The toxic oil syndrome may be divided into acute and chronic phases with a less well defined intermediate stage (Martinez-Tello et al. , 1982; Toxic Epidemic Study Group, 1982; Kilbourne et al. , 1983) . The acute clinical picture is shown by pleuropneumonia, fever, headache, exanthema and eosinophilia. The main pathological findings are in the lungs and consist of intense pulmonary interstitial oedema; patients die of respiratory insufficiency. In the intermediate phase some patients die of thromboembolic complications and skin oedema, pulmonary hypertension and some weight loss is seen.
In the chronic phase the patients develop a neuromuscular syndrome, schleroderma-like skin lesions, severe weight loss, sicca syndrome and die mainly due to infectious complications and respiratory failure. The muscular atrophy is considered to be neurogenic in origin and the peripheral nerve changes are probably secondary to changes in the vasculature with inflammatory lymphocytic infiltration of the perineurium (Martinez-Tello et al. , 1982; Ricoy et al. , 1983) .
The toxic oil syndrome is a new disease involving many organs. The most prominent feature is a non-necrotizing vasculitis which involves vessels of every type and size; this may be the primary event leading to other changes in many organs for example muscle, liver, salivary glands, pancreas, skin (Martinez-Tello et al., 1982), nervous system (Ricoy et al., 1983) , bone (Alonso-Ruiz et al., 1984) and the lung in late deaths (Fernandez-Segoviano et al. , 1983) . It remains undecided whether the early involvement of type 1 and type 2 pneumocytes is primary or secondary to the vascular lesions (Martinez-Tello et al. , 1982) .
Of particular interest is the suggestion that the toxic oil syndrome shows'many resemblances to graft versus host disease (Kammuller et al., 1984a) .
Nature of the toxic oil -Rape seed oil is not permitted to be imported into Spain for edible use and is only imported for industrial use when denatured. The denaturing agent used is 2% aniline. The diversion of industrial rape seed oil for edible consumption requires a refining process to remove the aniline. However, by a spontaneous reaction before refining, aniline will react with free (non-esterified) fatty acids (probably unsaturated) to form anilides and these will be more difficult to remove by the conventional refining process. These anilides were recommended (WHO, 1984) as a marker of toxic oil not because anilides might be the toxin but because oil with no anilides present was most unlikely to be involved in the toxic oil syndrome.
A further complication is that the rape seed oil after refining was delivered to processing firms who added or diluted it with other oils, e.g. 10-30% seed oils such as sunflower and grape seed oil, 30% of animal fats and possibly small amounts of poor quality olive oil (WHO, 1984) .
Since it seems probable that refined denaturated rape seed oil has been consumed without the development of disease, many possibilities exist:
(1) the normal refining process was modified and produced products other than anilides (cf. Vasquez-Roncero et al., 1984) (2) the original rape seed oil contained other natural constituents, which can react with aniline (Kammilller et al. , 1984b) (3) the oil was transported in tanker(s) which has been used for other substances which might react with the natural constituents of rape seed oil and/or aniline to produce toxin(s) (Aldridge & Connors, 1982) (4) case-related oils are difficult to identify due to the delay between consumption of the oil and the onset of symptoms, the large consumption of oil by Spanish families (0.09-0.85 litres per person per week; Rigau-Perez et al., 1984) and the very large number of samples of oil exchanged for olive oil after the announcement that oil was involved in the disease (5) the chemical toxin in the oil is unstable and has now disappeared. ' _.,
Experimental studies
No progress has been made in the identification of the substance(s) present in the oils which cause(s) the disease. Although there were some early reports that 'toxic oils' caused lung lesions in experimental animals, these results have not been confirmed. Samples of oil taken soon after the oil was suspected have produced no effects in a variety of species (R. Kimbrough, unpublished work). Other publications show biological activity of fatty acid anilides, e.g. immunogenicity (Marquet et al., 1984) , effects on pathways of prostaglandin synthesis (Gil et al., 1983) , neurotoxicity (Rodrigo et al., 1983) , lipogenesis (Casals et al., 1983) and membrane structure (Pagani et al., 1984) . Effects on lipogenesis have not been confirmed (V. J. Cunningham & S. Tucker, unpublished work); as yet no other publications confirming the observations on the other effects of fatty acid anilides have appeared. It is not possible to integrate these findings into a hypothesis on the mechanism of toxicity of anilides in the toxic oil syndrome.
Past and future approaches ' , 'The occurrence of this extraordinary disease in Spain has important implications for current and future responses with regard to food safety, contingency planning, epidemiological surveillance and research' (WHO, 1984) . It is clearly unsatisfactory that, after an epidemic of poisoning of this magnitude, we still do not know the substance causing it. In the more than 31/2 years since the outbreak many scientists have visited Spain and have produced reports (Aldridge & Connors, 1982), a WHO-sponsored meeting has produced a booklet (WHO, 1984) and a Scientific Steering Committee has been set up, held its first meeting and reported. None of these activities has resulted, in collaboration with Spanish scientists, in an effective mobilization of international scientific talent to plan and execute research on this important and difficult toxicological problem.
For the future, it seems unlikely that further work on 'case-related oils' will be productive, but simulation of the refining process might be more rewarding. In the present circumstances it will be vital to squeeze everything possible from available epidemiological information. Two questions are very important: (1) evidence whether anilide-contaminated rape seed oil has been consumed before the outbreak and (2) what other chemicals are carried by the bulk tankers used to transport the rape seed oil. Experimental research now will probably have to concentrate on the disease and devise hypotheses which link the main facets of the syndrome, e.g. endothelial cells, interstitial oedema in lungs, vasculitis and possible immunological responses resembling graft versus host disease. It is also important that in all countries clinicians and pathologists will be on the look out in man and animals for examples of diseases resembling this unique toxic syndrome. Toxicol. , 20, 989-992. ALONSO-RUIZ, A., ZEA-MENDOZA, A.C., GONZALEZ-LANZA, M. & GOMEZ- CATALAN, E. (1984) . Digital tuft alterations in toxic oil syndrome. Lancet, ii, 520-521.
